Senzime AB

6YC

Company Profile

  • Business description

    Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.

  • Contact

    Verkstadsgatan 8, hus 1
    Uppsala753 23
    SWE

    T: +46 18515640

    https://www.senzime.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    58

Stocks News & Analysis

stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.
stocks

Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,980.5029.500.33%
CAC 408,154.9115.970.20%
DAX 4025,578.853.840.02%
Dow JONES (US)51,863.69185.14-0.36%
FTSE 10010,708.3330.68-0.29%
HKSE25,087.7545.040.18%
NASDAQ27,244.28122.180.45%
Nikkei 22565,018.95882.701.38%
NZX 50 Index13,862.7512.73-0.09%
S&P 5007,764.640.06-0.00%
S&P/ASX 2008,786.4028.600.33%
SSE Composite Index3,952.132.220.06%

Market Movers